Publication:
Development of monoclonal antibodies specific to ToxA and ToxB of Vibrio parahaemolyticus that cause acute hepatopancreatic necrosis disease (AHPND)

dc.contributor.authorWangman P.
dc.contributor.authorChaivisuthangkura P.
dc.contributor.authorSritunyalucksana K.
dc.contributor.authorTaengchaiyaphum S.
dc.contributor.authorSenapin S.
dc.contributor.authorPengsuk C.
dc.contributor.authorSithigorngul P.
dc.contributor.authorLongyant S.
dc.date.accessioned2021-04-05T03:22:18Z
dc.date.available2021-04-05T03:22:18Z
dc.date.issued2017
dc.date.issuedBE2560
dc.description.abstractToxin A (ToxA) and toxin B (ToxB) of Vibrio parahaemolyticus, which cause acute hepatopancreatic necrosis disease (AHPND), were prepared in a bacterial supernatant from Chinese isolates (CN-VPAHPND) by washing bacterial colonies off of TSA cultures. The supernatant was subsequently used in mouse immunization to produce monoclonal antibodies (MAbs). Three groups of MAbs were selected: one MAb specific to ToxA, two MAbs specific to ToxB and one MAb specific to V. parahaemolyticus (CN-VPAHPND). The MAbs specific to ToxA and ToxB recognized all 10 VPAHPND isolates from China, Vietnam, Malaysia and Thailand, but did not bind to the 20 non-VPAHPND isolates from various other sources, including Vibrio spp. and other bacteria. The MAbs specific to toxins were used to detect the recombinant proteins of His-tagged ToxA and GST-ToxB with sensitivities of 200fmolspot−1 and 10fmolspot−1, respectively, as determined by dot-ELISA. The MAbs were used to detect the toxins produced by bacteria or shrimp tissue lysate spiked with bacteria in a complex tissue sample at concentrations as low as 1CFUml−1 after pre-enrichment of the bacteria for 6h. The third group of MAb was specific to CN-VPAHPND isolate but did not recognize the other 9 out of 10 VPAHPND isolates from Vietnam, Malaysia and Thailand. However, this MAb demonstrated cross-reactivity to 1 out of 20 of the non-VPAHPND isolates and 3 out of 9 of the V. alginolyticus isolates. These findings indicate that the AHPND epidemic in Southeast Asia was not caused by the CN-VPAHPND isolate. The MAbs specific to ToxA and ToxB produced in this study could be used to detect both toxins directly by dot blotting. © 2017 Elsevier B.V.
dc.format.mimetypeapplication/pdf
dc.identifier.citationAquaculture. Vol 474, (2017), p.75-81
dc.identifier.doi10.1016/j.aquaculture.2017.03.039
dc.identifier.issn448486
dc.identifier.other2-s2.0-85016138657
dc.identifier.urihttps://swu-dspace2.eval.plus/handle/123456789/4171
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.otherAntibody
dc.subject.otherBacterial disease
dc.subject.otherBacterium
dc.subject.otherEpidemic
dc.subject.otherImmunization
dc.subject.otherMolecular analysis
dc.subject.otherRodent
dc.subject.otherSymptom
dc.subject.otherToxin
dc.subject.otherChina
dc.subject.otherMalaysia
dc.subject.otherThailand
dc.subject.otherViet Nam
dc.subject.otherBacteria (microorganisms)
dc.subject.otherDecapoda (Crustacea)
dc.subject.otherVibrio
dc.subject.otherVibrio alginolyticus
dc.subject.otherVibrio parahaemolyticus
dc.titleDevelopment of monoclonal antibodies specific to ToxA and ToxB of Vibrio parahaemolyticus that cause acute hepatopancreatic necrosis disease (AHPND)
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85016138657&doi=10.1016%2fj.aquaculture.2017.03.039&partnerID=40&md5=c36e86c438114d0d9683bdf516440c8d

Files